Pipeline

Reprogramming the Cancer Immunity Cycle

We are advancing a pipeline of therapeutic agents designed to modulate the Cancer Immunity Cycle through multiple mechanisms and targets. These include cancer cells, components of tumor microenvironments and various types of immune cells.